Costs associated with emergency care and hospitalization for severe hypoglycemia.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  NMCD. Nutrition Metabolism and Cardiovascular Diseases

• Publication date

  2016-04-01

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1016/j.numecd.2016.01.007PMID 26897390
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Incidence and care‐related costs of severe hypoglycaemia requiring emergency treatment in Andalusia (Spain): the PAUEPAD project†

  2015cited by this paper
• A model of mild hypoglycemia

  2015cited by this paper
• An observational study of patient characteristics and mortality following hypoglycemia in the community

  2015cited by this paper
• Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States

  2015cited by this paper
• Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

  2015cited by this paper
• Hypoglycemia.

  2014cited by this paper
• The management of severe hypoglycemia by the emergency system: the HYPOTHESIS study.

  2014influential reference
• Glycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia

  2014cited by this paper
• Impact of hypoglycemia on patients with type 2 diabetes mellitus and their quality of life, work productivity, and medication adherence

  2014cited by this paper
• National estimates of insulin-related hypoglycemia and errors leading to emergency department visits and hospitalizations.

  2014cited by this paper
• Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

  2013cited by this paper
• Antiplatelet therapy and the outcome of subjects with intracranial injury: the Italian SIMEU study

  2013cited by this paper
• Glycemic control and diabetes-related health care costs in type 2 diabetes; retrospective analysis based on clinical and administrative databases

  2013cited by this paper
• Mechanisms of hypoglycemia-associated autonomic failure in diabetes.

  2013cited by this paper
• Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2013cited by this paper
• Do clinical standards for diabetes care address excess risk for hypoglycemia in vulnerable patients? A systematic review.

  2013cited by this paper
• Severe Hypoglycemia Is a Serious Complication and Becoming an Economic Burden in Diabetes

  2012cited by this paper
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2012cited by this paper
• Increased Mortality of Patients With Diabetes Reporting Severe Hypoglycemia

  2012cited by this paper
• The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients.

  2012cited by this paper
• The economic costs of hypoglycaemia

  2011cited by this paper
• Glucose control and vascular complications in veterans with type 2 diabetes.

  2009cited by this paper
• Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

  2008cited by this paper
• Effects of intensive glucose lowering in type 2 diabetes.

  2008cited by this paper
• Cost of hypoglycemia in patients with Type 2 diabetes in Sweden.

  2006cited by this paper
• Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use.

  2003cited by this paper
• Incidence and costs of severe hypoglycemia.

  2002cited by this paper
• [Frequency and costs of hospital stays for hypoglycemia in France in 1995].

  2000cited by this paper

• Reversible central adrenal insufficiency induced by recurrent insulinoma-related hypoglycemia: a case report and physiological modeling

  2025cites this paper
• Cost of hospitalization and length of stay of hypoglycemic events in hospitalized patients with diabetes mellitus: A cross-sectional study

  2025cites this paper
• Global economic burden of diabetic related hypoglycemia: a systematic review of cost of illness studies

  2025influential citation
• Budget Impact Analysis of the FreeStyle Libre Flash Continuous Glucose Monitoring System^® in Patients with Type 1 Diabetes Mellitus and Type 2 Diabetes Mellitus with Multiple Daily Insulin Injections in Argentina

  2023cites this paper
• Glucagon Prescribing and Costs Among U.S. Adults With Diabetes, 2011-2021.

  2023cites this paper
• Budget impact analysis of the freestyle libre flash continuous glucose monitoring system® in patients with diabetes mellitus type 1 in Chile

  2023cites this paper
• Glucagon Prescribing and Prevention of Hospitalization for Hypoglycemia in a Large Health System.

  2023cites this paper
• Continuous glucose monitoring (CGM) in a non-Icu hospital setting: The patient's journey.

  2023cites this paper
• Overtreatment of older people with type 2 diabetes—a high impact frequent occurrence in need of a new definition

  2022cites this paper
• Rekindling Hope for Remission: Current Impact of Diabetes for Our World's Future Health and Economy.

  2022cites this paper
• Effectiveness of the SUGAR intervention on hypoglycaemia in elderly patients with type 2 diabetes: A pragmatic randomised controlled trial.

  2022cites this paper
• Is hypoglycemia expensive in China?

  2021cites this paper
• CEOR_A_313577 503..518

  2021cites this paper
• Economic Impact of COVID-19 Lockdown on Italian NHS: Focus on Diabetes Mellitus

  2021cites this paper
• Economic burden of diabetes-related hypoglycemia on patients, payors, and employers.

  2021cites this paper
• Hypoglycemic episodes in hospitalized people with diabetes in Portugal: the HIPOS-WARD study

  2021cites this paper
• Burden of disease and costs associated with type 2 diabetes in emerging and established markets: systematic review analyses

  2020influential citation
• The Burden of Hypoglycemia in Patients With Insulin-Treated Diabetes Mellitus in China: Analysis of Electronic Medical Records From 4 Tertiary Hospitals.

  2020cites this paper
• Cost-Benefit Analysis in Health Care: the Case of Bariatric Surgery Compared With Diet.

  2020cites this paper
• Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study

  2020cites this paper
• CEOR_A_240183 177..189

  2020cites this paper
• Emergency attendance for acute hyper- and hypoglycaemia in the adult diabetic population of the metropolitan area of Milan: quantifying the phenomenon and studying its predictors

  2020cites this paper
• Cost of hospitalisation and length of stay due to hypoglycaemia in patients with diabetes mellitus: a cross-sectional study

  2020cites this paper
• Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real Studies I and II

  2020cites this paper
• Randomised controlled trial of pharmacist-led patient counselling in controlling hypoglycaemic attacks in older adults with type 2 diabetes mellitus (ROSE-ADAM): A study protocol of the SUGAR intervention

  2020cites this paper
• Costs and where to find them: identifying unit costs for health economic evaluations of diabetes in France, Germany and Italy

  2020cites this paper
• Deprescription in Elderly Patients with Type 2 Diabetes Mellitus.

  2020cites this paper
• Hypoglycemia

  2020cites this paper
• Mini-doses of glucagon to prevent hypoglycemia in children with type 1 diabetes refusing food: a case series

  2019cites this paper
• Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management

  2019cites this paper
• Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy

  2019cites this paper
• Insulin Glargine U100 Utilization in Patients with Type 2 Diabetes in an Italian Real-World Setting: A Retrospective Study

  2019cites this paper
• CEOR_A_218746 605..614

  2019cites this paper
• Impact of severe and symptomatic hypoglycemia on quality of life and fear of hypoglycemia in type 1 and type 2 diabetes. Results of the Hypos-1 observational study.

  2019cites this paper
• Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review

  2019cites this paper
• Hypoglycemia

  2019cites this paper
• Recurrent hospitalizations for severe hypoglycemia and hyperglycemia among U.S. adults with diabetes.

  2018cites this paper
• Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes

  2018cites this paper
• Improvement of Metabolic Control and Diabetes Management in Insulin-Treated Patients Results in Substantial Cost Savings for the German Health System

  2018cites this paper
• Do the patients referred to the emergency department really deserve an urgent medical intervention

  2018cites this paper
• Epidemiology of hypoglycaemia: Trends, risk factors and outcomes

  2018influential citation
• Intranasal glucagon for hypoglycaemia in diabetic patients. An old dream is becoming reality?

  2018cites this paper
• The Economic Burden of Insulin-Related Hypoglycemia in Adults with Diabetes: An Analysis from the Perspective of the Italian Healthcare System

  2018cites this paper
• Association of hypoglycaemia severity with clinical, patient‐reported and economic outcomes in US patients with type 2 diabetes using basal insulin

  2018cites this paper
• Efficacy and Safety of Insulin Glargine 300 U/mL in North Americans and Non-North Americans with Type 2 Diabetes: A Patient-Level Meta- Analysis of the EDITION 1, 2 and 3 Studies

  2017cites this paper
• Which treatment for type 2 diabetes associated with non-alcoholic fatty liver disease?

  2017cites this paper
• Deprescribing antihyperglycemic agents in older persons: Evidence-based clinical practice guideline.

  2017cites this paper
• Healthcare resource use, direct and indirect costs of hypoglycemia in type 1 and type 2 diabetes, and nationwide projections. Results of the HYPOS-1 study.

  2017cites this paper
• The Cost of Hypoglycemia

  2017cites this paper
• Healthcare resource use and associated costs of hypoglycemia in patients with type 2 diabetes prescribed sulfonylureas.

  2017cites this paper
• Comment on "Costs associated with emergency care and hospitalization for severe hypoglycemia".

  2017cites this paper
• Deprescribing antihyperglycemic agents in older persons

  2017cites this paper
• Coût des hospitalisations pour hypoglycémie en France chez les patients diabétiques de type 2 : étude fondée sur le PMSI et la base EGB de la CNAMTS

  2017cites this paper
• Analisi di Impatto Sul Budget di Empagliflozin Nel Trattamento Dei Pazienti Con Diabete di tipo 2 e Malattia Cardiovascolare Accertata

  2017cites this paper
• Analisi farmacoeconomica del trattamento con SGLT2 inibitori

  2017cites this paper
• Déprescription des antihyperglycémiants chez les personnes âgées: Guide de pratique clinique fondé sur les données probantes.

  2017cites this paper
• Response to letter to the editor: Gallo F et al., "The economic burden of severe hypoglycemia: Two sides of the same coin" Nutr Metab Cardiovasc Dis. 2016;26:850-851.

  2016cites this paper
• Are severe hypoglycemic episodes in diabetes correctly identified by administrative data? Evidence of underreporting from the HYPOTHESIS study

  2016cites this paper
• Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy

  2016cites this paper
• The economic burden of severe hypoglycemia: Two sides of the same coin. Comment on G. Veronese and Coll. Costs associated with emergency care and hospitalization for severe hypoglycemia.

  2016cites this paper